Risk-benefit considerations when prescribing phosphodiesterase-5 inhibitors in children.

about

Risk-benefit considerations when prescribing phosphodiesterase-5 inhibitors in children.

Item

http://www.wikidata.org/entity/Q38368957

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Risk-benefit considerations when prescribing phosphodiesterase-5 inhibitors in children.

@en

type

Item

label

Risk-benefit considerations when prescribing phosphodiesterase-5 inhibitors in children.

@en

prefLabel

Risk-benefit considerations when prescribing phosphodiesterase-5 inhibitors in children.

@en

P1476

Risk-benefit considerations when prescribing phosphodiesterase-5 inhibitors in children.

@en

P2093

Alan G Magee

http://www.w3.org/2001/XMLSchema#string

Siân Bentley

http://www.w3.org/2001/XMLSchema#string

Sukeshi Makhecha

http://www.w3.org/2001/XMLSchema#string

P2860

Sildenafil ameliorates effects of inhaled nitric oxide withdrawal

Childhood idiopathic pulmonary arterial hypertension: a national cohort study.

Clinical features of paediatric pulmonary hypertension: a registry study

Initial experience with tadalafil in pediatric pulmonary arterial hypertension.

PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy.

Safety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial hypertension.

Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy.

Impact of oral sildenafil on exercise performance in children and young adults after the fontan operation: a randomized, double-blind, placebo-controlled, crossover trial

Haemodynamic evaluation of pulmonary hypertension.

The heart in human dystrophinopathies.

P304

633-642

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14740338.2015.1022527

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25746065

http://www.w3.org/2001/XMLSchema#string